EMEA-001301-PIP01-12
Key facts
| Active substance |
Isavuconazonium sulfate
|
| Therapeutic area |
Infectious diseases
|
| Decision number |
P/0134/2013
|
| PIP number |
EMEA-001301-PIP01-12
|
| Pharmaceutical form(s) |
|
| Condition(s) / indication(s) |
Treatment of Candida infections
|
| Route(s) of administration |
|
| Contact for public enquiries |
Basilea Medical Ltd
E-mail: medical.information@basilea.com
Tel. +41 616061400 Fax +41 616061216 |
| Decision type |
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
|